The U.S. Food and Drug Administration announced it issued an emergency use authorization for the first over-the-counter (OTC) at-home diagnostic test for COVID-19.
The Ellume COVID-19 Home Test is a rapid, lateral flow antigen test that detects fragments of proteins from any individual 2 years of age or older.
The Ellume COVID-19 Home Test is the first COVID-19 test that can be used entirely at home without a prescription, says the FDA.
At-Home COVID-19 Test Authorized
Many Young Asthma Patients Noncompliant With COVID-19 Measures
Many do not believe COVID-19 is more severe for people suffering from asthma
U.S. COVID-19 Death Toll Hits 300,000 as Vaccine Rollout Begins
And, later this week, Moderna vaccine expected to receive recommendation from FDA advisory panel
Interest High in Affordable Care Act Sign-Ups
Interest in the annual insurance sign-ups has increased as the country struggles with the pandemic
FDA Approves First Over-the-Counter Fully At-Home Test for COVID-19
Ellume COVID-19 Home Test detects SARS-CoV-2 virus protein fragments on nasal swab samples
Risk for COVID-19 Infection Increased With Common Cancers
Risk for COVID-19 elevated for individuals with recent cancer diagnosis; those with cancer and COVID-19 have worse outcomes